iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

QubeHealth Investments raises funding from New Horizon, others

10 Nov 2022 , 07:57 AM

QubeHealth, an early-stage fintech business with a focus on healthcare, announced on Wednesday that it has raised an undisclosed pre-series-A round, which was led by New Horizon Ventures in the US, ThinKuvate in Singapore, and Keiretsu Forum, an existing investor.

The company claims that this round of financing gave them a runway of more than twenty months and included participation from Axiomatic Ventures, Inflection Point Ventures, an existing investor, and several angel investors from India and the US.

The money received will be used to grow the company, invest more in developing the technical foundation for “healthcare commerce,” and broaden its healthcare marketplace.

Related Tags

  • Pre-Series capital
  • QubeHealth Investments
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.